N-Glycolylneuraminic acid-containing GM3 ganglioside (GM3 (Neu5Gc-GM3))

N-Glycolylneuraminic acid-containing GM3 ganglioside is a glycosphingolipid found predominantly on the outer leaflet of plasma membranes. Structurally, it consists of a ceramide backbone linked to an oligosaccharide chain terminating with N-glycolylneuraminic acid (Neu5Gc), a sialic acid variant not synthesized by humans but present due to dietary incorporation or aberrant expression. This molecule plays key roles in modulating signal transduction pathways involved in cell proliferation, differentiation, apoptosis, immune recognition—including acting as an endogenous ligand for Toll-like receptor 4—and serves as both a precursor for more complex gangliosides and an important structural component within lipid rafts. Its abnormal accumulation has been implicated in several diseases—most notably various cancers where it acts both as a biomarker and potential immunotherapeutic target—and autoimmune neuropathies where it may function as an autoantigen. The unique presence of Neu5Gc makes this molecule particularly interesting from both diagnostic and therapeutic perspectives but also raises safety considerations regarding immunogenicity when used clinically.

Other names

Neu5Gc-GM3N-glycolyl GM3Ganglioside GM3 (N-glycolyl variant)Monosialodihexosylganglioside (N-glycolyl form)Hematoside (less specific; may refer to other forms)

Induction of apoptosis through modulation of growth factor receptor activity or direct immune targeting by anti-Neu5Gc-GM3 antibodies. Inhibition of tumor cell proliferation by interfering with cellular adhesion and migration. Modulation of innate immune responses via TLR4 binding/activation or inhibition depending on fatty acid composition.